Skip to main content

Animations

MJFF Publications

5871 - 5880 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2016
  • 2016
  • 2019
  • 2020
  • 2021
  • 2020
  • 2013
  • 2022
  • Summary Details
    OPEN
    Title: Abstracts from the 50th European Society of Human Genetics Conference: Posters
    Journal Name: European Journal of Human Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/s41436-019-0684-x
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(16)30328-3
    Citation Count: 380
  • Summary Details
    OPEN
    Title: Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(16)00071-5
    Citation Count: 92
  • Summary Details
    OPEN
    Title: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Developing therapies for Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PD
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-021-10586-7
    Citation Count: 11
  • Summary Details
    OPEN
    Title: EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-020-04817-8
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-013-1121-x
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Application of longitudinal item response theory models to modeling Parkinson’s disease progression
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psp4.12853
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.